Page 6 - Wyliew Vale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wyliew vale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wyliew Vale Today - Breaking & Trending Today

California Public Employees Retirement System Sells 18,250 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

California Public Employees Retirement System lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 2.8% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 631,534 shares of the company’s stock after selling 18,250 shares during the period. California Public Employees Retirement System’s holdings in Neurocrine Biosciences were worth $75,430,000 at […] ....

United States , San Diego , Julie Cooke , Kevin Charles Gorman , Wyliew Vale , Neurocrine Biosciences , Zurcher Kantonalbank Zurich Cantonalbank , Kevinc Gorman , California Public Employees Retirement System , Canaccord Genuity Group , Securities Exchange Commission , Jupiter Asset Management Ltd , Royal Bank , Wells Fargo Company , Neurocrine Biosciences Inc , Holdings Channel , Get Rating , Public Employees Retirement System , Sigma Investments , Kantonalbank Zurich Cantonalbank , Asset Management , Strs Ohio , Genuity Group , Exchange Commission , Charles Gorman , Visit Holdingschannel ,

Neurocrine Biosciences (NASDAQ:NBIX) PT Lowered to $125.00 at Barclays

Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price cut by Barclays from $131.00 to $125.00 in a research note issued to investors on Thursday, The Fly reports. Several other research analysts have also recently issued reports on NBIX. StockNews.com initiated coverage on Neurocrine Biosciences in a report on Thursday, March 16th. They issued […] ....

San Diego , United States , Eric Benevich , Neurocrine Biosciences , Julie Cooke , Kevinc Gorman , Wyliew Vale , First Republic Investment Management Inc , Larson Financial Group , Investors Services , Securities Exchange Commission , Neurocrine Biosciences Company Profile , Canaccord Genuity Group , Neurocrine Biosciences Inc , Wells Fargo Company , Securian Asset Management Inc , Meiji Yasuda Asset Management Co Ltd , Get Rating , Genuity Group , Moderate Buy , Exchange Commission , Republic Investment Management , Asset Management , Financial Group , Neurocrine Biosciences Daily , Nasdaq Nbix ,

TD Asset Management Inc Sells 99,494 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

TD Asset Management Inc reduced its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 72.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 38,158 shares of the company’s stock after selling 99,494 shares during the quarter. TD Asset Management Inc’s holdings in Neurocrine Biosciences were worth $4,558,000 at the end […] ....

San Diego , United States , Williamh Rastetter , Neurocrine Biosciences , Kevinc Gorman , Wyliew Vale , Kevin Charles Gorman , Securities Exchange Commission , Cantor Fitzgerald , Canaccord Genuity Group , Congress Asset Management Co , Td Asset Management Inc , Vanguard Group Inc , York Mellon Corp , Bellevue Group , Neurocrine Biosciences Inc , Brown Advisory Inc , Management Inc , Get Rating , New York Mellon Corp , Asset Management , Brown Advisory , Director William , Exchange Commission , Charles Gorman , Visit Holdingschannel ,

Neurocrine Biosciences (NASDAQ:NBIX) Price Target Cut to $111.00 by Analysts at Mizuho

Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) had its target price decreased by Mizuho from $116.00 to $111.00 in a research note released on Thursday, The Fly reports. Other research analysts also recently issued reports about the company. Evercore ISI upgraded Neurocrine Biosciences from an in-line rating to an outperform rating and set a $130.00 target […] ....

United States , San Diego , Piper Sandler , Neurocrine Biosciences , Kevinc Gorman , Eric Benevich , Wyliew Vale , Kevin Charles Gorman , Neurocrine Biosciences Inc , Assetmark Inc , Morgan Stanley , Hussman Strategic Advisors Inc , Illinois Municipal Retirement Fund , Lmcg Investments , Cantor Fitzgerald , Neurocrine Biosciences Company Profile , Securities Exchange Commission , Get Rating , Moderate Buy , Charles Gorman , Exchange Commission , Municipal Retirement Fund , Strategic Advisors , Neurocrine Biosciences Daily , Nasdaq Nbix , Lower Price Target ,

Handelsbanken Fonder AB Sells 2,100 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Handelsbanken Fonder AB lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Rating) by 13.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 13,167 shares of the company’s stock after selling 2,100 shares during the period. Handelsbanken Fonder AB’s holdings in Neurocrine Biosciences were worth […] ....

San Diego , United States , Sakhalinskaya Oblast , Neurocrine Biosciences , Kevinc Gorman , Wyliew Vale , Kevin Charles Gorman , Piper Sandler , Covestor Ltd , Cm Bidwell Associates Ltd , Acadian Asset Management , Piershale Financial Group Inc , Cantor Fitzgerald , Neurocrine Biosciences Inc , Handelsbanken Fonder , Get Rating , Asset Management , Financial Group , Charles Gorman , Visit Holdingschannel , Neurocrine Biosciences Daily , Nasdaq Nbix , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,